Actualización sobre Tinea del cuero cabelludo

1. Leung AKC, Hon KL, Leong KF, Barankin B, Lam JM. Tinea capitis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):58-68. doi:10.2174/1872213X14666200106145624

2. Rodríguez-Cerdeira C, Martínez-Herrera E, Szepietowski JC, et al. A systematic review of worldwide data on tinea capitis: analysis of the last 20 years. J Eur Acad Dermatol Venereol. 2021;35(4):844- 883. doi:10.1111/jdv.16951

3. Gnat S, Łagowski D, Nowakiewicz A. Major challenges and perspectives in the diagnostics and treatment of dermatophyte infections. J Appl Microbiol. 2020;129(2):212-232. doi:10.1111/jam.14611

4. Fuller LC, Barton RC, Mohd Mustapa MF, Proudfoot LE, Punjabi SP, Higgins EM. British Association of Dermatologists’ guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014;171(3):454-463. doi:10.1111/bjd.13196

5. Genedy RM, Sorour OA, Elokazy MAW. Trichoscopic signs of tinea capitis: a guide for selection of appropriate antifungal. Int J Dermatol. 2021;60(4):471-481. doi:10.1111/ijd.15289

6. Kupsch C, Gräser Y. The potential of molecular diagnostics in routine dermatology. In: Bouchara JP, Nenoff P, Gupta AK, Chaturvedi V, (Eds.). Dermatophytes and Dermatophytoses. Springer International Publishing; 2021:339-353. doi:10.1007/978-3-030-67421-2_16

7. Salehi Z, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M. Molecular epidemiology, genetic diversity, and antifungal susceptibility of major pathogenic dermatophytes isolated from human dermatophytosis. Front Microbiol. 2021;12:643509. doi:10.3389/ fmicb.2021.643509

8. Gnat S, Łagowski D, Nowakiewicz A, Dyląg M, Osińska M, Sawicki M. Detection and identification of dermatophytes based on currently available methods – a comparative study. J Appl Microbiol. 2021;130(1):278-291. doi:10.1111/jam.14778

9. Stein M, Tran V, Nichol KA, et al. Evaluation of three MALDI-TOF mass spectrometry libraries for the identification of filamentous fungi in three clinical microbiology laboratories in Manitoba, Canada. Mycoses. 2018;61(10):743-753. doi:10.1111/myc.12800

10. Sacheli R, Henri A, Seidel L, et al. Evaluation of the new Id-Fungi plates from Conidia for MALDI-TOF MS identification of filamentous fungi and comparison with conventional methods as identification tool for dermatophytes from nails, hair and skin samples. Mycoses. 2020;63(10):1115-1127. doi:10.1111/myc.13156

11. Gupta AK, Bamimore MA, Renaud HJ, Shear NH, Piguet V. A network meta-analysis on the efficacy and safety of monotherapies for tinea capitis, and an assessment of evidence quality. Pediatr Dermatol. 2020;37(6):1014-1022. doi:10.1111/pde.14353

12. Bortolussi R, Martin S, Audcent T, Barton M, Top K. Antifungal agents for common outpatient paediatric infections | Canadian Paediatric Society. https://www.cps.ca/en/documents/position/ antifungal-agents-common-infections. Accessed August 30, 2021.

13. Patel D, Castelo-Soccio LA, Rubin AI, Streicher JL. Laboratory monitoring during systemic terbinafine therapy for pediatric onychomycosis. JAMA Dermatol. 2017;153(12):1326. doi:10.1001/jamad ermatol.2017.4483

14. Li DG, Mostaghimi A. Utility of baseline transaminase monitoring during systemic terbinafine therapy for pediatric onychomycosis. JAMA Dermatol. 2018;154(5):626-627. doi:10.1001/jamadermat ol.2018.0094

15. Wang Y, Lipner SR. Retrospective analysis of abnormal laboratory test results in pediatric patients prescribed terbinafine for superficial fungal infections. J Am Acad Dermatol. 2021;85(4):1042-1044. doi:10.1016/j.jaad.2021.01.073